from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1372/-

LFCtreatmentdescriptionclass of inhibitor

-0.169

Amikacinug/mL Amikacintranslation

-0.375

Cap5-10ug/mL Capreomycintranslation

0.169

Rox10-50 ug/mL Roxithromycintranslation

1.259

SM2-5 ug/mL Streptomycintranslation

0.191

Tet5-10 ug/mL Tetracyclinetranslation

0.456

Rif0.2-5ug/mL Rifampicintranscription

0.293

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.714

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.829

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.410

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.958

Clofazimine10-13 ug/mL Clofaziminerespiration

0.013

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.889

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.725

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.193

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.020

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.169

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.037

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.181

KCN5-20 ug/mL Potassium cyaniderespiration

-1.445

NaN30.2-2 mM Sodium aziderespiration

-0.826

Nigericin50 uM Nigericinrespiration

0.147

TRC10-150 ug/mL Triclosanrespiration

0.564

TRZ10-25 ug/mL Thioridazinerespiration

-0.162

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.024

menadione6-10 ug/mL Menadionerespiration

0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.426

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.043

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.051

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.526

NRP_1Non-replicating persistence stage 1dosRassociated

-0.471

Amp0.2mg/mL AmpicillincellWall

-0.044

Cephalexin20-100 ug/mL CephalexincellWall

1.107

Cerulenin0.32-5 ug/mL CerulenincellWall

0.711

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.105

EMB10-20 ug/mL EthambutolcellWall

-0.538

Eta12-40 ug/mL EthionamidecellWall

-1.021

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.064

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.476

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.491

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.619

BZA0.12 mg/mL BenzamidearomaticAmides

0.813

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.258

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.629

H2O24 mM hydrogen peroxideDNAdamaging

-0.076

Levo10 ug/mL LevofloxacinDNAdamaging

1.150

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.083

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.308

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.335

UVUV-irradiationDNAdamaging

-0.454

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.080

Antimycin12.5-50 ug/mL Antimycin A?

-0.700

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.394

PA_110-50 ug/mL Antitubercular compound PA-1?

0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.563

PA8240.2-2 ug/mL PA-824?

0.217

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.404

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.375

Verapamil50 uM Verapamil?

-1.714

mercaptoethanol2 mM 2-Mercaptoethanol?

0.940

methoxatin10-20 ug/mL Methoxatin?